Status:
COMPLETED
Impact of Tolerability Issues on Chronic Pain
Lead Sponsor:
Janssen-Ortho Inc., Canada
Conditions:
Pain
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study was to assess the impact of opioid tolerability-related issues experienced by Canadian chronic pain patients. Approximately 170 patients were enrolled from 16 recruiting cent...
Detailed Description
This was a multi-center, non-interventional, observational study of patients receiving opioid treatment for chronic pain. Relevant Canadian data such as pain severity, treatment adherence, medical res...
Eligibility Criteria
Inclusion
- Chronic pain of non-malignant origin (nociceptive, neuropathic or mixed pain types)
- Opioid requirement \>=4 days per week, including new to opioids (\<3 months exposure), opioid experienced (\>3 months exposure), non-opioids or weak opioids (e.g., NSAIDS or Tramacet) for breakthrough or adjunctive use only
- Internet access; read/understand English or French.
Exclusion
- \- Current or previous history of opioid addiction, abuse, or diversion
Key Trial Info
Start Date :
February 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT01484301
Start Date
February 1 2010
End Date
August 1 2010
Last Update
March 20 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.